XXX

Xeris Pharmaceuticals, Inc. 5.0% 15-JUL-2025

No trades
See on Supercharts
Overview
Analysis

Key terms


Outstanding amount
‪15.20 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
5.00% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
0.93%
Maturity date
Jul 15, 2025
Term to maturity
7 months

About Xeris Pharmaceuticals, Inc. 5.0% 15-JUL-2025


Issuer
Xeris Pharmaceuticals, Inc.
Sector
Health Technology
Issue date
Jun 30, 2020
FIGI
BBG00VR7NMN7
Xeris Biopharma is a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables. The company’s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous (SC) and intramuscular (IM) delivery of highly concentrated, non-aqueous, ready-to-use formulations of peptides, proteins, antibodies, and small molecules using syringes, auto-injectors, multi-dose pens, and infusion pumps. Xeris’ platforms have the potential to offer distinct advantages over existing formulations of marketed and development-stage products. In particular, XeriSol and XeriJect offer the opportunity to eliminate reconstitution, enable long-term room temperature stability, significantly reduce injection volume, and eliminate the requirement for intravenous (IV) infusion. These attributes can lead to products that are easier to use by patients, caregivers, and health practitioners and reduce costs for payers and the healthcare system.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.